Fideuram Asset Management Ireland dac Invests $14.25 Million in Danaher Corporation $DHR

Fideuram Asset Management Ireland dac purchased a new position in shares of Danaher Corporation (NYSE:DHR) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 66,409 shares of the conglomerate’s stock, valued at approximately $14,247,000. Danaher makes up approximately 1.1% of Fideuram Asset Management Ireland dac’s portfolio, making the stock its 20th biggest position.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Elevated Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter valued at approximately $26,000. JPL Wealth Management LLC purchased a new stake in Danaher in the 3rd quarter valued at approximately $25,000. WFA of San Diego LLC purchased a new stake in Danaher in the 2nd quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher in the 3rd quarter valued at approximately $27,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in Danaher in the 4th quarter valued at approximately $33,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 4.2%

Shares of Danaher stock opened at $180.47 on Friday. The company has a fifty day moving average price of $182.29 and a 200 day moving average price of $207.65. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market cap of $127.73 billion, a price-to-earnings ratio of 34.91, a price-to-earnings-growth ratio of 2.31 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the prior year, the company posted $1.88 EPS. Equities research analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.

Analyst Ratings Changes

A number of research firms recently issued reports on DHR. JPMorgan Chase & Co. reduced their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Morgan Stanley cut their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 price target on Danaher in a report on Friday, April 17th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Twenty research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $238.24.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.